Ongoing
A study of an HPV VLP vaccine in a cohort of HIV positive girls and women
Learn MoreTerminated
Open label, dose escalating phase I/II study of TG4040 (MVA-HCV) in patients chronically infected with hepatitis C virus (Genotype I) who relapsed from previous pegylated interferon/ribavirin treatment
Learn MoreEnrolling
A prospective clinical cohort of HIV and hepatitis C virus co-infected patients
Learn MoreCompleted
A multicenter randomized, double-blind, controlled study of NGX-4010 for the treatment of painful HIV-associated neuropathy: Trial results
Learn MoreCompleted
Trial of Citalopram for the Prevention of Depression
Learn MoreCompleted
A pilot study assessing the efficacy of pneumococcal vaccine in HIV patients: delayed versus immediate immunization: Trial results
Learn MoreEnrolling
Using a novel assay to detect syphilis infection early in asymptomatic men who have sex with men (MSM) undergoing STI screening
Learn MoreEnrolling
Association of vitamin D insufficiency with non-alcoholic fatty liver disease in HIV mono-infected patients
Learn MoreCompleted
Acceptability and implications of the rapid hepatitis C virus screening test among provincial prison inmates in Quebec: A pilot study
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
